Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology-Reference-Cited by-同舟云学术

Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology

Published:2019-02-19 Issue:24 Volume:38 Page:4657-4668
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Recio Carlota^ORCID,Guerra Borja,Guerra-Rodríguez Miguel,Aranda-Tavío Haidée,Martín-Rodríguez Patricia,de Mirecki-Garrido Mercedes,Brito-Casillas Yeray,García-Castellano José M.,Estévez-Braun Ana,Fernández-Pérez Leandro

Funder

MINECO

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-019-0752-3.pdf

Reference90 articles.

1. O’Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med. 2015;66:311–28.

2. Rawlings JS, Rosler KM, Harrison DA. The JAK/STAT signaling pathway. J Cell Sci. 2004;117(Pt 8):1281–3.

3. Kiu H, Nicholson SE. Biology and significance of the JAK/STAT signalling pathways. Growth Factors. 2012;30:88–106.

4. Miklossy G, Hilliard TS, Turkson J. Therapeutic modulators of STAT signalling for human diseases. Nat Rev Drug Discov. 2013;12:611–29.

5. Sonkin D, Palmer M, Rong X, Horrigan K, Regnier CH, Fanton C, et al. The identification and characterization of a STAT5 gene signature in hematologic malignancies. Cancer Biomark. 2015;15:79–87.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A New Strategy for Adult T‐Cell Leukemia Treatment Targeting Glycogen Synthase Kinase‐3β;European Journal of Haematology;2024-09-06

2. The treatment of Tofacitinib for rosacea through the inhibition of the JAK/STAT signaling pathway;Archives of Dermatological Research;2024-08-24

3. Lipopolymer/siRNA Nanoparticles Targeting the Signal Transducer and Activator of Transcription 5A Disrupts Proliferation of Acute Lymphoblastic Leukemia;ACS Pharmacology & Translational Science;2024-08-15

4. The treatment of Tofacitinib for rosacea through the inhibition of the JAK/STAT signaling pathway;2024-07-19

5. Comprehensive analysis of single cell and bulk RNA sequencing reveals the heterogeneity of melanoma tumor microenvironment and predicts the response of immunotherapy;Inflammation Research;2024-06-19